Abstract
Dividing classrooms may reduce the risk of SARS-CoV-2 outbreaks in schools. We investigate how classroom cohorting strategies, which downsize and isolate groups, may curb the spread of SARS-CoV-2. Using agent-based modelling based on a rich multi-country network dataset comprising 507 classrooms and 12,291 students, we assess random cohorting and three network-based strategies that consider students’ out-of-school contacts with classmates. Investigating effects on the number of cross-cohort transmissions, overall infections, and quarantines, our findings suggest that all cohorting strategies help to contain outbreaks, but that minimizing out-of-school contact between cohorts is most effective. Since this strategy may be hard to implement in practice, we show that a network chain nomination procedure and splitting classes by gender, both of which are easier to realize, also outperform random cohorting considerably. For all cohorting strategies, we find that rota-systems with instruction in alternating weeks contain outbreaks more effectively than same-day in-person instruction.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
no funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
NA - analysis of secondary data
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.